CS191321B2 - Process for preparing optically active 11-deoxy-16-aryloxy-omega-tetranorprostaglandines - Google Patents
Process for preparing optically active 11-deoxy-16-aryloxy-omega-tetranorprostaglandinesInfo
- Publication number
- CS191321B2 CS191321B2 CS766713A CS671376A CS191321B2 CS 191321 B2 CS191321 B2 CS 191321B2 CS 766713 A CS766713 A CS 766713A CS 671376 A CS671376 A CS 671376A CS 191321 B2 CS191321 B2 CS 191321B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- tetranorprostaglandines
- deoxy
- omega
- aryloxy
- optically active
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/624,486 US3984400A (en) | 1975-10-21 | 1975-10-21 | 11-Desoxy-16-aryl-ω-tetranorprostaglandins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS191321B2 true CS191321B2 (en) | 1979-06-29 |
Family
ID=24502191
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS766713A CS191321B2 (en) | 1975-10-21 | 1976-10-18 | Process for preparing optically active 11-deoxy-16-aryloxy-omega-tetranorprostaglandines |
| CS775880A CS191343B2 (en) | 1975-10-21 | 1976-10-18 | Method of production intermediates for preparing novel analoques of natural prostaglandins |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS775880A CS191343B2 (en) | 1975-10-21 | 1976-10-18 | Method of production intermediates for preparing novel analoques of natural prostaglandins |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US3984400A (cs) |
| JP (2) | JPS5251353A (cs) |
| AR (1) | AR213831A1 (cs) |
| AT (1) | AT360673B (cs) |
| BE (1) | BE847447A (cs) |
| BG (1) | BG31070A3 (cs) |
| CA (1) | CA1092103A (cs) |
| CH (1) | CH619930A5 (cs) |
| CS (2) | CS191321B2 (cs) |
| DD (1) | DD128590A5 (cs) |
| DE (1) | DE2646878A1 (cs) |
| DK (1) | DK472976A (cs) |
| ES (1) | ES452538A1 (cs) |
| FI (1) | FI762990A (cs) |
| GB (1) | GB1520958A (cs) |
| GR (1) | GR63621B (cs) |
| HU (1) | HU175022B (cs) |
| IE (1) | IE44016B1 (cs) |
| IL (1) | IL50657A (cs) |
| LU (1) | LU76045A1 (cs) |
| NL (1) | NL163780C (cs) |
| NO (1) | NO763451L (cs) |
| NZ (1) | NZ182297A (cs) |
| PH (1) | PH11472A (cs) |
| PL (1) | PL112539B1 (cs) |
| PT (1) | PT65727B (cs) |
| RO (1) | RO71900A (cs) |
| SE (1) | SE7610995L (cs) |
| SU (2) | SU727139A3 (cs) |
| ZA (1) | ZA766204B (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4365077A (en) * | 1975-06-23 | 1982-12-21 | Pfizer Inc. | 11-Desoxy-16-aryloxy-ω-tetranorprostaglandins |
| ZA77160B (en) * | 1976-02-13 | 1977-11-30 | Upjohn Co | Prostaglandin analogs |
| US4058564A (en) * | 1976-07-26 | 1977-11-15 | The Upjohn Company | Aliphatic 2-decarboxy-2-hydroxymethyl-13,14-didehydro-PG compounds |
| US4140721A (en) * | 1976-07-26 | 1979-02-20 | The Upjohn Company | 2-Decarboxy-2-hydroxymethyl-13,14-didehydro-17-phenyl-PGA, PGD and PGE compounds |
| US4177346A (en) * | 1976-08-06 | 1979-12-04 | Pfizer Inc. | 1,5-Disubstituted-2-pyrrolidones |
| JPS6210843Y2 (cs) * | 1981-01-23 | 1987-03-14 | ||
| JPS59190734U (ja) * | 1983-06-06 | 1984-12-18 | 庄田商事株式会社 | 薄板用連続送り装置 |
| US4576962A (en) * | 1983-10-19 | 1986-03-18 | The Procter & Gamble Company | Prostaglandin analogues |
| US4883614A (en) * | 1984-07-27 | 1989-11-28 | Hoffman-La Roche Inc. | Phenyl substituted-2,4,6,8-nonatetraenoic acid |
| US4780251A (en) * | 1984-07-27 | 1988-10-25 | Hoffman-La Roche Inc. | Phenyl substituted-2,4,6,8-nonatetraenoic acid |
| MX2014001496A (es) | 2011-08-12 | 2014-04-30 | Ascendis Pharma As | Composicion de liberacion sostenida de prostaciclina. |
| US10544915B2 (en) * | 2017-04-27 | 2020-01-28 | Valeo North America, Inc. | Vehicle lamp assembly having an improved heat sink with light shield |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3840573A (en) * | 1970-12-21 | 1974-10-08 | Searle & Co | 2-(3-hydroxy-3-optionally alkylated-1-alkynyl)-3-hydroxy-5-oxygenated cyclopent-1-enealkanoic acids,optical isomers thereof and esters corresponding |
| US3932389A (en) * | 1974-12-11 | 1976-01-13 | Pfizer Inc. | 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins |
-
1975
- 1975-10-21 US US05/624,486 patent/US3984400A/en not_active Expired - Lifetime
-
1976
- 1976-07-30 IE IE1703/76A patent/IE44016B1/en unknown
- 1976-10-04 SE SE7610995A patent/SE7610995L/xx unknown
- 1976-10-08 NO NO763451A patent/NO763451L/no unknown
- 1976-10-08 GR GR51887A patent/GR63621B/el unknown
- 1976-10-11 NZ NZ182297A patent/NZ182297A/xx unknown
- 1976-10-11 IL IL50657A patent/IL50657A/xx unknown
- 1976-10-12 CA CA263,138A patent/CA1092103A/en not_active Expired
- 1976-10-13 GB GB42614/76A patent/GB1520958A/en not_active Expired
- 1976-10-14 PH PH19004A patent/PH11472A/en unknown
- 1976-10-16 DE DE19762646878 patent/DE2646878A1/de not_active Withdrawn
- 1976-10-18 CS CS766713A patent/CS191321B2/cs unknown
- 1976-10-18 CS CS775880A patent/CS191343B2/cs unknown
- 1976-10-18 ZA ZA766204A patent/ZA766204B/xx unknown
- 1976-10-19 PT PT65727A patent/PT65727B/pt unknown
- 1976-10-20 HU HU76PI549A patent/HU175022B/hu unknown
- 1976-10-20 DD DD7600195365A patent/DD128590A5/xx unknown
- 1976-10-20 DK DK472976A patent/DK472976A/da unknown
- 1976-10-20 ES ES452538A patent/ES452538A1/es not_active Expired
- 1976-10-20 BE BE1007708A patent/BE847447A/xx unknown
- 1976-10-20 FI FI762990A patent/FI762990A/fi not_active Application Discontinuation
- 1976-10-21 CH CH1331676A patent/CH619930A5/fr not_active IP Right Cessation
- 1976-10-21 JP JP51126771A patent/JPS5251353A/ja active Pending
- 1976-10-21 PL PL1976193183A patent/PL112539B1/pl unknown
- 1976-10-21 LU LU76045A patent/LU76045A1/xx unknown
- 1976-10-21 AT AT785876A patent/AT360673B/de active
- 1976-10-21 NL NL7611660.A patent/NL163780C/xx not_active IP Right Cessation
- 1976-10-21 AR AR265178A patent/AR213831A1/es active
- 1976-10-21 BG BG7634499A patent/BG31070A3/xx unknown
- 1976-10-21 SU SU762414464A patent/SU727139A3/ru active
- 1976-10-21 RO RO7688159A patent/RO71900A/ro unknown
-
1977
- 1977-07-14 SU SU772502098A patent/SU900806A3/ru active
-
1978
- 1978-11-20 JP JP14323078A patent/JPS5490168A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU174396B (hu) | Sposob poluchenija 17-al'fa-gidroksi-kortikosteroidov | |
| JPS5273833A (en) | Process for preparing orthoo hydroxyarylaldehyde | |
| CS191321B2 (en) | Process for preparing optically active 11-deoxy-16-aryloxy-omega-tetranorprostaglandines | |
| CS191310B2 (en) | Process for preparing 11-deoxy-16-aryloxy-omega-tetranorprostaglandines | |
| GB1548032A (en) | Process for preparing amono-acid admides | |
| JPS5239608A (en) | Process for preparing perfluoroalkyliodide teromer | |
| HU172964B (hu) | Sposob poluchenija n-aril-n-/1-l-4-piperidinil/-aril-acetamidov | |
| JPS52233A (en) | Process for preparing paraaalkylphenol | |
| HU174650B (hu) | Sposob poluchenija l-piroglutamil-l-prolinamida | |
| JPS5328146A (en) | Process for preparing optically active aresrolone | |
| JPS5273803A (en) | Process for preparing halogenoalkene | |
| CS189001B2 (en) | Process for preparing optically active 13,14-dehydro-11-deoxyprostaglandines | |
| JPS51115453A (en) | Process for preparing 22naphtylaminee 11sulphonate | |
| GB1542488A (en) | Process for preparing alpha-amino-gamma-methylmercaptobutyronitrile | |
| HU174888B (hu) | Sposob poluchenija 1-naftil-n-metil-karbamata | |
| CS191296B2 (en) | Process for preparing optically active or racemic fluorprostaglandine | |
| JPS51125467A (en) | Process for preparing graftcopolymer | |
| HU174777B (hu) | Sposob poluchenija 2-acilamino-oksazolov | |
| IL50682A0 (en) | Process for preparing dihalovinylcyclopropanecarboxylates | |
| JPS5210202A (en) | Process for preparing c2hydrocarbon | |
| HU174633B (hu) | Sposob poluchenija glikolal'degida | |
| HU174667B (hu) | Sposob poluchenija omega-amino-alkankarbonil-aril-amidov | |
| JPS532460A (en) | Process for preparing optically active sulfoxide | |
| EG12462A (en) | Process for preparing imidazolobenzodiazepines | |
| PT66747B (en) | Process for preparing of optically active trans-hexahydro-dibenzopyranones |